Sarepta therapeutics inc

See also: Sarepta therapeutics cambridgeSarepta therapeuticsSarepta therapeutics.comSarepta therapeutics ceoSarepta therapeutics 10kSarepta therapeutics ark

Keywords Suggestions

Sarepta therapeutics inc

Sarepta therapeutics inc news

Sarepta therapeutics inc. srpt

Sarepta therapeutics inc stock

Sarepta therapeutics inc cambridge

Sarepta therapeutics inc latest news

Sarepta therapeutics inc stock price

Sarepta therapeutics inc price

( Please select at least 2 keywords )

Related websites

Sarepta Therapeutics Biopharmaceutical Company for …

Sarepta Therapeutics Announces Preliminary Financial Results for the Third Quarter Ended September 30, 2021 10/12/2021 Sarepta Therapeutics Announces Proposed $500,000,000 Public …

Sarepta.com   DA: 15 PA: 15 MOZ Rank: 31

SRPT Stock Price Sarepta Therapeutics Inc. Stock Quote

  • is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases

Marketwatch.com   DA: 19 PA: 21 MOZ Rank: 42

Sarepta Therapeutics, Inc. (SRPT) Stock Price, News, Quote

  • Analyst Report: Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs

Finance.yahoo.com   DA: 17 PA: 11 MOZ Rank: 31

Is Sarepta Therapeutics Inc (SRPT) Stock a Smart Value

  • Sarepta Therapeutics Inc is around the middle of the Healthcare sector according to InvestorsObserver.SRPT received an overall rating of 7, which means that it scores higher than 7% of stocks
  • Additionally, Sarepta Therapeutics Inc scored a 66 in the Healthcare sector, ranking it higher than 66% of stocks in that sector.

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 79

Why Sarepta Therapeutics Fell 14.7% This Week The …

  • Sarepta Therapeutics (NASDAQ:SRPT), a biotech company that specializes in genetic therapies for rare diseases, dropped 14.7% this week, according to data from S&P Global Market Intelligence

Fool.com   DA: 12 PA: 50 MOZ Rank: 67

Why Sarepta Therapeutics Tumbled Today The Motley Fool

  • NASDAQ: SRPT $81.22 down $-2.97 (-3.53%) Average returns of all recommendations since inception
  • Cost basis and return based on …

Fool.com   DA: 12 PA: 50 MOZ Rank: 68

Sarepta Therapeutics Inc. (NASDAQ: SRPT) Reports

  • (NASDAQ: SRPT) has announced its preliminary Q3 2021 financial results
  • The company expects net product revenues of $166.9 million relative to net revenue of $121.4 million a year ago
  • Sarepta has $1.6 billion in cash and equivalents

Biopharmajournal.com   DA: 20 PA: 50 MOZ Rank: 77

Analysts Mean recommendation for Sarepta Therapeutics Inc

  • had a pretty Dodgy run when it comes to the market performance
  • The 1-year high price for the company’s stock is recorded $174.49 on 01/04/21, with the lowest value was $65.30 for the same time period, recorded on 07/27/21.

Investchronicle.com   DA: 19 PA: 50 MOZ Rank: 77

Sarepta Therapeutics Inc careers complete history

  • 18 Jobs HR Coordinator Sarepta Therapeutics Inc Cambridge, MA The HR Coordinator will serve as the "Face of Sarepta," being the first Sarepta employee to welcome and onboard new hires to the organization
  • Full-time Last updated 2 hours ago Senior Manager, Environmental Health & Safety Sarepta Therapeutics Inc Andover, MA Last updated 2 hours ago Senior

Jobsearcher.com   DA: 15 PA: 31 MOZ Rank: 55

Buy or Sell Sarepta Therapeutics Inc. (SRPT) Stock Now

  • (NASDAQ:SRPT) went down by -3.53% from its latest closing price compared to the recent 1-year high of $181.83
  • The company’s stock price has collected -11.03% of loss in the last five trading sessions

Newsheater.com   DA: 14 PA: 50 MOZ Rank: 74

October 29th Options Now Available For Sarepta

  • Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options begin trading today, for the October 29th expiration
  • At Stock Options Channel, our YieldBoost formula has looked up …

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 75

Sarepta Therapeutics Inc. (NASDAQ:SRPT) Has Reached A

  • Statistics highlight that Sarepta Therapeutics Inc
  • is scoring comparatively lower than the scores of other players of the relevant industry
  • The company added 9.47% of value to its shares in past 6 months, showing an annual growth rate of -1.27% while that of industry is 6.90.

Marketingsentinel.com   DA: 21 PA: 50 MOZ Rank: 83

Sarepta Therapeutics, Inc. (SRPT) Stock Forum & Discussion

  • Find the latest Sarepta Therapeutics, Inc
  • (SRPT) stock discussion in Yahoo Finance's forum
  • Share your opinion and gain insight from other stock traders and investors.

Finance.yahoo.com   DA: 17 PA: 21 MOZ Rank: 51

SAREPTA THERAPEUTICS, INC. : SRPT Stock Price

  • is a commercial-stage biopharmaceutical company
  • The Company is focused on the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases.

Marketscreener.com   DA: 22 PA: 47 MOZ Rank: 83

SRPT Sarepta Therapeutics Inc. Stock Price & News

  • View the latest Sarepta Therapeutics Inc
  • (SRPT) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Wsj.com   DA: 11 PA: 24 MOZ Rank: 50

SRPT Sarepta Therapeutics Inc. Stock Overview (U.S

  • is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases.

Barrons.com   DA: 15 PA: 24 MOZ Rank: 55

SRPT: Sarepta Therapeutics Inc

  • is a commercial-stage biopharmaceutical company
  • The Company is focused on the discovery and development of ribonucleic acid (RNA)-targeted therapeutics…

Cnbc.com   DA: 12 PA: 12 MOZ Rank: 41

$SRPT: Investors will love the forecast for Sarepta

  • Sarepta Therapeutics Inc has a market cap of $7590829900
  • Stock analysis is a method for investors and traders to make buying and selling decisions
  • Investors and traders try to gain an edge in the markets by making informed decisions through analyzing the past and current data
  • The ultimate goal is to arrive at a number that can

Wallstreetfacts.com   DA: 19 PA: 50 MOZ Rank: 87

Is Sarepta Therapeutics Inc (SRPT) a Bad Choice in

  • Sarepta Therapeutics Inc (SRPT) stock is trading at $89.92 as of 12:39 PM on Thursday, Sep 23, a gain of $2.44, or 2.8% from the previous closing price of $87.47
  • The stock has traded between $86.99 and $90.65 so far today
  • So far 502,371 shares have traded compared to average volume of 711,869 shares.

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 94

SRPT Sarepta Therapeutics Inc. Profile MarketWatch

  • is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the …

Marketwatch.com   DA: 19 PA: 37 MOZ Rank: 76

Sarepta Therapeutics, Inc.'s (SRPT) CEO Doug Ingram

  • (NASDAQ:SRPT) Cantor Fitzgerald 2021 Virtual Global Healthcare Conference September 27, 2021 01:20 PM ET Company Participants Doug Ingram - President and CEO Ian

Seekingalpha.com   DA: 16 PA: 50 MOZ Rank: 87

Sarepta Therapeutics, Inc.

  • SRPT investment & stock information
  • Get the latest Sarepta Therapeutics, Inc
  • SRPT detailed stock quotes, stock …

Zacks.com   DA: 13 PA: 17 MOZ Rank: 52

Sarepta Therapeutics Inc. (SRPT): Skating on Thin Ice

  • (NASDAQ:SRPT) went up by 4.70% from its latest closing price compared to the recent 1-year high of $181.83
  • The company’s stock price has collected 7.38% of gains in the last five trading sessions
  • Press Release reported on 09/14/21 that Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual …

Newsheater.com   DA: 14 PA: 50 MOZ Rank: 87

Sarepta Therapeutics, Inc. in Tumwater, WA Company Info

  • is a Washington Foreign Profit Corporation filed On June 21, 2013
  • The company's filing status is listed as Active and its File Number is 603312687
  • The Registered Agent on file for this company is Corporation Service Company and is located at 300 Deschutes Way Sw Ste 208 Mc-Csc1, Tumwater, WA 98501.

Bizapedia.com   DA: 17 PA: 33 MOZ Rank: 74

Sarepta Therapeutics Inc (SRPT) Quote

  • Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases
  • It targets a broad range of diseases while focusing on …

Morningstar.com   DA: 19 PA: 23 MOZ Rank: 67

Sarepta Therapeutics, Inc.

  • is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases.

Thestreet.com   DA: 17 PA: 11 MOZ Rank: 54

Sarepta Therapeutics Biopharmaceutical Company for Rare

  • Sarepta is engineering solutions for rare diseases with science that is on the forefront of precision genetic medicine
  • Our platforms include: gene therapy, RNA technologies, and gene editing
  • We are in a daily race to save lives stolen or impacted by rare disease.

Sareptatherapeutics.ch   DA: 26 PA: 26 MOZ Rank: 79

Sarepta Therapeutics Inc. (NASDAQ: SRPT): Is It A Gold

  • share prices are performing particularly well not compared to other companies within the same industry
  • As is evident from the statistics, the company’s shares have risen 29.47 percent over the past six months and at a -4.50% annual growth rate that is well below the industry average of 6.90%.

Marketingsentinel.com   DA: 21 PA: 50 MOZ Rank: 99

Sarepta Therapeutics Announces Inducement Grants Under

  • Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) CAMBRIDGE, Mass., Sept
  • 30, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc

Globenewswire.com   DA: 21 PA: 50 MOZ Rank: 100

Sarepta Therapeutics opens Columbus R&D center for gene

  • On the same day Sarepta Therapeutics Inc
  • welcomed politicians and patients to the grand opening of its Columbus research hub, the company started the …

Bizjournals.com   DA: 19 PA: 50 MOZ Rank: 99

Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram Presents

  • (NASDAQ:SRPT) Morgan Stanley 19th Annual Global Healthcare Conference Call September 13, 2021 1:15 PM ET Company Participants
  • Doug Ingram - Chief Executive Officer

Seekingalpha.com   DA: 16 PA: 50 MOZ Rank: 97

Sarepta Therapeutics’ SRP-9001 Shows Sustained Functional

  • is leading a revolution in precision genetic medicine and every day is an opportunity to change the lives of people living with raredisease
  • The Company has built an impressive position in Duchenne muscular dystrophy (DMD) and in gene therapies for limb-girdle muscular dystrophies (LGMDs), mucopolysaccharidosis type

Stocktitan.net   DA: 18 PA: 50 MOZ Rank: 100

Sarepta Therapeutics (SRPT)

  • is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases.

Forbes.com   DA: 14 PA: 32 MOZ Rank: 79

Sarepta Therapeutics Inc. Company & People SRPT Barron's

  • is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases.

Barrons.com   DA: 15 PA: 39 MOZ Rank: 88

Exploring Growth Opportunities In Sarepta Therapeutics Inc

  • (NASDAQ:SRPT) shares, rose in value on Friday, 09/03/21, with the stock price up by 1.33% to the previous day’s close as strong demand from buyers drove the stock to $80.51
  • Actively observing the price movement …

Stocksregister.com   DA: 18 PA: 50 MOZ Rank: 15

Sarepta Therapeutics Inc. Com SRPT Pivot Points

  • Com (NASDAQ: SRPT) report was produced using proprietary algorithums developed by Stock Traders Daily.Over the past 20 years our metholdology has been refined to help identify the best strategies for both individual stocks and the stock markets, with prudent risk controls.

News.stocktradersdaily.com   DA: 26 PA: 50 MOZ Rank: 14

SRPT Sarepta Therapeutics, Inc. Stock Quote

  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases
  • The company offers EXONDYS 51 injection to treat duchenne muscular dystrophy (DMD) in patients who have a

Finviz.com   DA: 10 PA: 11 MOZ Rank: 58

Analysts Are Bullish on These Healthcare Stocks: Sarepta

  • Sarepta Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $117.64, representing a 22.3% upside
  • In a report issued on September 27, Robert W
  • Baird also maintained a Buy rating on the stock with a $110.00 price target.

Analystratings.com   DA: 22 PA: 50 MOZ Rank: 12

Sarepta Therapeutics Inc. Com (SRPT) Trading Report

  • The objective of this specific report is to optimize trading in Sarepta Therapeutics Inc
  • Com (NASDAQ: SRPT) while incorporating prudent risk controls
  • Warning: This is a static report, the data below was valid at the time of the publication, but support and resistance levels for SRPT change over time, so the report should be updated regularly.

News.stocktradersdaily.com   DA: 26 PA: 50 MOZ Rank: 11

Sarepta Therapeutics Inc Stock Quote: SRPT Stock News

SRPT, Sarepta Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines

Research.investors.com   DA: 22 PA: 50 MOZ Rank: 10

Should I Buy Sarepta Therapeutics Inc (SRPT)

Sarepta Therapeutics Inc (NASDAQ:SRPT) was in 34 hedge funds’ portfolios at the end of the second quarter of 2021.The all time high for this statistic is …

Insidermonkey.com   DA: 21 PA: 50 MOZ Rank: 9

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
Samsbenefits.com 268 days leftGoDaddy.com, LLCThe Constant Company, LLC
Jasonstudiosf.com 315 days leftCloud Yuqu LLCDomain Name Services
Hokiasli.com 109 days leftPSI-USA, Inc. dba Domain RobotDomain Name Services
Citpekalongan.com 300 days leftNameCheap, Inc.Google LLC
Wetseal.com2 years, 81 days leftNetwork Solutions, LLCCloudflare, Inc.
Kullalaw.com1 year, 177 days leftTucows Domains Inc.DigitalOcean, LLC
Picohospitality.com1 year, 89 days leftGoDaddy.com, LLCGoDaddy.com, LLC
Magicmouse.com 232 days leftNameSilo, LLCA2 Hosting, Inc.
Certipaq.com1 year, 20 days leftInfomaniak Network SARIPE Network Coordination Centre
Ecoisme.com 292 days leftNameCheap, Inc.Liquid Web, L.L.C

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 Site-Stats.org. All rights reserved. Email: [email protected]